Examining How a Text Message-based Educational Intervention Influences COVID-19 Testing
Addressing COVID-19 Testing Disparities in Vulnerable Populations Using a Community JITAI (Just in Time Adaptive Intervention) Approach: RADx-Underserved Populations (RADxUP) Phase III
2 other identifiers
interventional
384
1 country
3
Brief Summary
In this Phase III study, the investigators will build off of the Phase II embedded study with some adjustments to the design to address new research priorities that examine an intervention that is network informed and delivered through community health worker interactions plus digitally-delivered intervention content with the goal of increasing COVID-19 testing and vaccination. This model, if proven effective, can be scaled up to address COVID-19 and other future pandemics. The investigators will utilize the sample of intervention priority census block groups (PBGs) used in Phase II and will recruit and enroll participants not previously enrolled in either phase I or II from these PBGs using convenience sampling methods. The investigators will use a historical control group consisting of participants from our control arm in Phase II who completed both their baseline and follow-up surveys embedded in the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2023
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 3, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 12, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 12, 2024
CompletedFirst Submitted
Initial submission to the registry
July 16, 2025
CompletedFirst Posted
Study publicly available on registry
July 20, 2025
CompletedResults Posted
Study results publicly available
January 6, 2026
CompletedJanuary 6, 2026
December 1, 2025
1.7 years
July 16, 2025
December 12, 2025
December 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Number of Participants Who Self-Reported Use of a COVID-19 Antigen or PCR Test
The number of participants who self-reported use of COVID-19 antigen test or PCR Test using individual-level data in the past 60 days
Baseline
Number of Participants Who Self-Reported Use of a COVID-19 Antigen or PCR Test
The number of participants who self-reported use of COVID-19 antigen test or PCR Test using individual-level data in the past 60 days
8 weeks
Secondary Outcomes (3)
Number of Participants Who Self-reported Receiving COVID-19 Vaccination
Baseline
Number of Participants Who Self-reported Receiving COVID-19 Vaccination
8 weeks
Number of Participants Who Self-reported Used Mitigation Measures if a Positive Test is Obtained
Baseline, 8 weeks
Study Arms (2)
Text message-based education intervention
EXPERIMENTALA text message-based COVID-19 education intervention with support from community health workers.
Historical Control Group
OTHERParticipants in this Historical Control Group completed the prior Phase II embedded study, in which they received CDC-designed COVID-19 testing brochures and completed pre- and post-intervention surveys only.
Interventions
Participants received CDC-designed COVID-19 testing brochures and completed pre- and post-intervention surveys as part of the Phase II embedded study.
The intervention consisted of enhanced behavioral and educational text messages, up to three messages each week, providing updates on COVID-19 testing and vaccination. The text messages included digitally delivered intervention content such as a video with low-literacy instructions for administering the rapid antigen tests, guidance if they tested positive (e.g., quarantine, notify contacts, wearing a mask), and other relevant strategies and content focused on increasing COVID-19 testing and vaccination.
Eligibility Criteria
You may qualify if:
- having a smartphone that accepts text messages
You may not qualify if:
- having been diagnosed with COVID-19 in the past 30 days based on a positive test (antigen or PCR) or a clinical diagnosis
- having tested for COVID-19 with PCR or antigen test within the past 30 days
- not being available in the recruitment area in the next 60 days
- having been an embedded study participant
- having been a snowball study participant.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
The University of Texas Health Science Center at Houston School of Public Health Brownsville Regional Campus
Brownsville, Texas, 78520, United States
The University of Texas Health Science Center at Houston School of Public Health Houston Main Campus
Houston, Texas, 77030, United States
The University of Texas at Tyler
Tyler, Texas, 75799, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Belinda M Reininger, DrPH
- Organization
- The University of Texas Health Science Center at Houston
Study Officials
- PRINCIPAL INVESTIGATOR
Maria E Fernandez, PhD
The University of Texas Health Science Center, Houston
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor and Regional Campus Dean in Brownsville
Study Record Dates
First Submitted
July 16, 2025
First Posted
July 20, 2025
Study Start
April 3, 2023
Primary Completion
December 12, 2024
Study Completion
December 12, 2024
Last Updated
January 6, 2026
Results First Posted
January 6, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share